A detailed history of Apollon Financial, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Apollon Financial, LLC holds 1,503 shares of LLY stock, worth $1.22 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares
1,503
Previous 1,210 24.21%
Holding current value
$1.22 Million
Previous $1.1 Billion 21.54%
% of portfolio
0.39%
Previous 0.35%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$772.14 - $960.02 $226,237 - $281,285
293 Added 24.21%
1,503 $1.33 Billion
Q2 2024

Jul 19, 2024

BUY
$724.87 - $909.04 $172,519 - $216,351
238 Added 24.49%
1,210 $1.1 Billion
Q1 2024

May 02, 2024

BUY
$592.2 - $792.28 $120,216 - $160,832
203 Added 26.4%
972 $756 Million
Q4 2023

Feb 12, 2024

BUY
$525.19 - $619.13 $403,871 - $476,110
769 New
769 $448 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $771B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Apollon Financial, LLC Portfolio

Follow Apollon Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Apollon Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Apollon Financial, LLC with notifications on news.